In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde
- PMID: 100563
- DOI: 10.1093/infdis/138.3.378
In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde
Abstract
Several biological activities of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP for muramyl dipeptide), a synthetic immunoadjuvant, are inhibited after glycosidation with p-aminophenol. Thus, this glycoside does not induce an increase humoral antibody response in mice when injected in saline, although it retains its stimulatory effect on circulating antibodies and delayed hypersensitivity after administration in a water-in-oil emulsion. The capacity of MDP to stimulate mouse spleen cells is lost, and, moreover, the analogue is unable to increase nonspecific resistance to infection under conditions where MDP is active. After cross-linking of the beta-D-p-aminophenyl glycoside of MDP with glutaraldehyde, several biological activities of MDP are recovered. Moreover, the cross-linked oligomer (molecular weight, approximately 6,000 daltons) is able to stimulate the uptake of thymidine by spleen cells from a strain of mice weakly responsive to MDP and is more active than MDP in protecting mice against bacterial challenge.
Similar articles
-
Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.Infect Immun. 1980 Mar;27(3):826-31. doi: 10.1128/iai.27.3.826-831.1980. Infect Immun. 1980. PMID: 7380554 Free PMC article.
-
[Synthesis and protective activity of beta-glycosides of N-acetylmuramyl-L-alanyl-D-isoglutamine with alkylalicyclic and arylaliphatic aglycons].Bioorg Khim. 2005 Nov-Dec;31(6):637-44. Bioorg Khim. 2005. PMID: 16363137 Russian.
-
Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).Biochem Biophys Res Commun. 1978 Nov 29;85(2):684-90. doi: 10.1016/0006-291x(78)91216-0. Biochem Biophys Res Commun. 1978. PMID: 367370 No abstract available.
-
Activation of immune responses by muroctasin.Arzneimittelforschung. 1988 Jul;38(7A):976-7. Arzneimittelforschung. 1988. PMID: 3056427 Review.
-
Muramyl peptides as possible endogenous immunopharmacological mediators.Microbiol Immunol. 1983;27(9):723-32. doi: 10.1111/j.1348-0421.1983.tb00636.x. Microbiol Immunol. 1983. PMID: 6358804 Review.
Cited by
-
Immunotherapy of Lewis lung carcinoma with hydrosoluble peptidoglycan monomer (PGM).Cancer Immunol Immunother. 1983;15(2):84-6. doi: 10.1007/BF00199695. Cancer Immunol Immunother. 1983. PMID: 6553516 Free PMC article.
-
Colony-stimulating activity induced by synthetic muramyl peptides: variation with chemical structure and association with anti-infectious activity.Infect Immun. 1984 Nov;46(2):495-500. doi: 10.1128/iai.46.2.495-500.1984. Infect Immun. 1984. PMID: 6334030 Free PMC article.
-
Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.Infect Immun. 1980 Mar;27(3):826-31. doi: 10.1128/iai.27.3.826-831.1980. Infect Immun. 1980. PMID: 7380554 Free PMC article.
-
Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier.Proc Natl Acad Sci U S A. 1979 Dec;76(12):6557-61. doi: 10.1073/pnas.76.12.6557. Proc Natl Acad Sci U S A. 1979. PMID: 293743 Free PMC article.
-
Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).Proc Natl Acad Sci U S A. 1980 Aug;77(8):4933-7. doi: 10.1073/pnas.77.8.4933. Proc Natl Acad Sci U S A. 1980. PMID: 6776530 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources